Expanding pharmacists' scope of practice to improve access to health care and the management of chronic diseases.
The bill seeks to expand access to care by leveraging pharmacists' expertise. It permits pharmacists to prescribe medications and devices to improve patient outcomes. Beginning December 1, 2026, pharmacists may prescribe immunizations, opioid antagonists, epinephrine autoinjectors, antihistamine agents, tobacco cessation products, medications to prevent human immunodeficiency virus, tuberculin purified protein derivative products, hormonal contraception, medications to treat or prevent diseases related to travel, and other drugs or devices.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.